Faced with a depressed economy, Hyliion Holdings Corporation (HYLN) Stock offers an opportunity
Northland Capital lowered the price target for the Hyliion Holdings Corporation (NYSE:HYLN) stock from “an Outperform” to “a Market perform”. The rating was released on October 12, 2023, according to finviz. The research report from Cantor Fitzgerald has downgraded the stock from Overweight to Neutral, with a price target set at $5. In their research […]
Grupo Financiero Galicia ADR (GGAL) Stock to return to profitability in the near future
JP Morgan lowered the price target for the Grupo Financiero Galicia ADR (NASDAQ:GGAL) stock from “a Neutral” to “an Underweight”. The rating was released on January 31, 2022, according to finviz. The latest trade, Performances and Moving Averages give us the following Picture The firm’s stock price fluctuated -6.29% within the last five trades and […]
Don’t be afraid of PMV Pharmaceuticals Inc (PMVP) Stock despite uncertainty and doubt
Craig Hallum raised the price target for the PMV Pharmaceuticals Inc (NASDAQ:PMVP) stock to “a Buy”. The rating was released on May 13, 2024, according to finviz. The research report from Ladenburg Thalmann has initiated the stock to Buy, with a price target set at $7. The stock was upgraded by Oppenheimer, who disclosed in […]
The market value of Nevro Corp (NVRO) Stock is expected to soar in the coming months
Citigroup lowered the price target for the Nevro Corp (NYSE:NVRO) stock from “a Neutral” to “a Sell”. The rating was released on May 22, 2024, according to finviz. The research report from RBC Capital Mkts has downgraded the stock from Outperform to Sector Perform, with a price target set at $20. The stock was downgraded […]
Rigel Pharmaceuticals (RIGL) Stock Has More Upside Than Fundamentals Suggest
Piper Sandler raised the price target for the Rigel Pharmaceuticals (NASDAQ:RIGL) stock to “a Neutral”. The rating was released on April 03, 2023, according to finviz. The research report from Piper Sandler has downgraded the stock from Overweight to Neutral, with a price target set at $1. The stock was downgraded by Cantor Fitzgerald, who […]
Getting Ready for the Bounce: First Solar Inc (FSLR) Stock
Mizuho raised the price target for the First Solar Inc (NASDAQ:FSLR) stock from “a Buy” to “a Neutral”. The rating was released on May 30, 2024, according to finviz. The research report from Evercore ISI has upgraded the stock from In-line to Outperform, with a price target set at $227. The stock was upgraded by […]
Cava Group Inc (CAVA) Stock creates opportunities due to its volume and complexity
JP Morgan raised the price target for the Cava Group Inc (NYSE:CAVA) stock from “an Overweight” to “a Neutral”. The rating was released on June 03, 2024, according to finviz. We previously noted in another research note published on May 30, 2024 by Piper Sandler that downgraded the stock from an Overweight to a Neutral […]
The performance of Semtech Corp. (SMTC) Stock has improved
Craig Hallum raised the price target for the Semtech Corp. (NASDAQ:SMTC) stock to “a Buy”. The rating was released on June 06, 2024, according to finviz. We previously noted in another research note published on April 01, 2024 by Craig Hallum that reiterated the stock to a Buy with a price target of $36 for […]
A positive surprise is on the way: Avidity Biosciences Inc (RNA) Stock
BofA Securities raised the price target for the Avidity Biosciences Inc (NASDAQ:RNA) stock to “a Buy”. The rating was released on May 03, 2024, according to finviz. The research report from Evercore ISI has upgraded the stock from In-line to Outperform, with a price target set at $20. The stock was downgraded by Evercore ISI, […]
EyePoint Pharmaceuticals Inc (EYPT) Stock offers help to cash-strapped investors
JP Morgan raised the price target for the EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) stock to “an Overweight”. The rating was released on January 22, 2024, according to finviz. The research report from Robert W. Baird has initiated the stock to Outperform, with a price target set at $33. The stock was initiated by Chardan Capital Markets, […]
